Targeted cytosine deaminase-uracil phosphoribosyl transferase suicide gene therapy induces small cell lung cancer-specific cytotoxicity and tumor growth delay

Camilla L Christensen, Torben Gjetting, Thomas Tuxen Poulsen, Frederik Cramer, Jack A Roth, Hans S Poulsen

    30 Citationer (Scopus)

    Abstract

    Small cell lung cancer (SCLC) is a highly malignant cancer for which there is no curable treatment. Novel therapies are therefore in great demand. In the present study we investigated the therapeutic effect of transcriptionally targeted suicide gene therapy for SCLC based on the yeast cytosine deaminase (YCD) gene alone or fused with the yeast uracil phosphoribosyl transferase (YUPRT) gene followed by administration of 5-fluorocytosine (5-FC) prodrug. Experimental design: The YCD gene or the YCD-YUPRT gene was placed under regulation of the SCLC-specific promoter insulinoma-associated 1 (INSM1). Therapeutic effect was evaluated in vitro in SCLC cell lines and in vivo in SCLC xenografted nude mice using the nonviral nanoparticle DOTAP/cholesterol for transgene delivery.
    OriginalsprogEngelsk
    TidsskriftClinical Cancer Research
    Vol/bind16
    Udgave nummer8
    Sider (fra-til)2308-19
    Antal sider12
    ISSN1078-0432
    DOI
    StatusUdgivet - 15 apr. 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Targeted cytosine deaminase-uracil phosphoribosyl transferase suicide gene therapy induces small cell lung cancer-specific cytotoxicity and tumor growth delay'. Sammen danner de et unikt fingeraftryk.

    Citationsformater